Another vaccine candidate is taking a step forward.
Novavax announced Monday it is starting a phase three trial for its vaccine candidate in the United States and Mexico.
Tampa will host a site for the clinical trial.
Another vaccine candidate is taking a step forward.
Novavax announced Monday it is starting a phase three trial for its vaccine candidate in the United States and Mexico.
Tampa will host a site for the clinical trial.
Novavax COVID-19 Vaccine Becomes
5th to Reach Phase 3 Trial in the US.
On Monday, Novavax announced the beginning
of..